Mark Hong
Papers
1
Total Citations
76
H-Index
1
About
Dr. Mark Hong is a leading urologic surgeon and researcher whose work has significantly advanced the field of robotic-assisted radical prostatectomy, with a particular focus on improving postoperative functional outcomes. His primary research areas include surgical technique innovation, urinary continence recovery, and oncologic outcomes in prostate cancer treatment. Dr. Hong’s most notable contribution is his pioneering work on posterior rhabdosphincter reconstruction, a surgical technique designed to accelerate the return of urinary continence after prostate removal. His landmark Phase II randomized clinical trial, published in 2011 and cited over 76 times, provided rigorous evidence that this reconstruction can improve early continence rates, establishing a new standard in surgical practice. Beyond this, Dr. Hong has been instrumental in refining robotic surgical protocols and mentoring the next generation of minimally invasive urologic surgeons. His work has been recognized with multiple institutional awards for clinical excellence and innovation. For students and researchers, Dr. Hong exemplifies how a focused, evidence-based approach to surgical technique can directly enhance patient quality of life, making him a key figure in modern urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1